Psoriasis
Atopic Dermatitis
Wound Healing
Skin Grafting
Non-GLP Skin Toxicology
Stroke
Neurodegenerative Diseases (AD’s, PD’s)
Psychopharmacology
CNS-PK
Pulmonary Arterial Hypertension
Ischemia Reperfusion
Heart failures (HFpEF & HFrEF)
Gastrointestinal disorders
Metabolic disturbances
Regulatory food toxicology
ETAP-Lab is compliant with
About us
ETAP-Lab is an independent Contract Research Organization (CRO)
ETAP-Lab provides preclinical pharmacology and research services, as well as scientific expertise, to Pharmaceutical and Agro-Food industries. Our activity focuses on In Vivo models of pathologies and toxicology studies in rodents to support drug and nutraceutic R&D for our sponsors.
Since the foundation in 1991, ETAP-Lab’s Scientists have an in-depth expertise in pathology modeling with rodents. By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value. All our models are customizable and original specific models can be set-up and validated on request.
Subscribe to our newsletter
Our News
-
Meet ETAP-Lab at NLSDays 2024 for Partnering Opportunities
ETAP-Lab will attend the upcoming NLSDays on next September 18 - 19, 2024, in Malmö, Sweden for partnering opportunities. We are delighted to participate for the first time to Nordic Life
-
ETAP-Lab’s Dermatological expertise showcased at the ESDR meeting 2024
ETAP-Lab will showcase its expertise at the 53rd ANNUAL ESDR MEETING on next September 4-7, 2024, in Lisbon (Portugal), organized by the European Society for Dermatological Research. 🎯 Discover our gold
-
ETAP-Lab’s future facilities unveiled
To support our growth and our preclinical research activities, we're investing in new facilities! We are glad to unveil the new plans for ETAP-Lab's future building in Nancy-Chavigny, in the Brabois